Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?

References (10)

1. Arıkan F, Yıldız Y, Ercan T, Oruç Ö, Akçay S, Yılmaz F, Toptaş T. Hydroxychloroquine-associated thrombotic thrombocytopenic purpura. Turk J Hematol 2020;37:302-304
2. Sookaromdee P, Wiwanitkit V. Hydroxychloroquine, TTP, COVID-19 and SLE. Turk J Hematol 2021;38:99-100
3. Page EE, Little DJ, Vesely SK, George JN. Quinine-induced thrombotic microangiopathy a report of 19 patients. Am J Kidney Dis 2017;70:686-695
4. Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL, Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL. Ticlopidine and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl 2009;112:20-24
5. Albiol N, Awol R, Martino R. Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19. Ann Hematol 2020;99:1673-1674
6. Hindilerden F, Yonal-Hindilerden I, Akar E, Kart-Yasar K. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case. Thromb Res 2020;195:136-138
7. Capecchi M, Mocellin C, Abbruzzese C, Mancini I, Prati D, Peyvandi F. Dramatic presentation of acquired thombotic thrombocytopenic purpura associated with COVID-19. Haematologica 2020;105:540
8. Al-Ansari RY, Bakkar M, Abdalla L, Sewify K. Critical care COVID-19 patient with a picture of thrombotic thrombocytopenic purpura. Eur J Case Rep Intern Med 2020;7:002143
9. Galbiati V, Papale A, Kummer E, Corsini E. In vitro models to evaluate drug- induced hypersensitivity: Potential test based on activation of dendritic cells. Front Pharmacol 2016;7:204
10. Martinelli N, Montagnana M, Pizzolo F, Friso S, Salvagno GL, Forni GL, Gianesin B, Morandi M, Lunardi C, Lippi G, Polati E, Olivieri O, De Franceschi L. A relative ADAMTS13 deficiency supports the presence of secondary microangiopathy in COVID 19. Thromb Res 2020;193;170-172.